| 前收市價 | 4.4000 |
| 開市 | 4.4000 |
| 買盤 | 1.5000 |
| 賣出價 | 6.5000 |
| 拍板 | 30.00 |
| 到期日 | 2025-02-21 |
| 今日波幅 | 4.4000 - 6.2700 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 4 |
Insider MonkeyIs Genmab A/S (GMAB) One of the Best Revenue Growth Stocks to Buy According to Analysts?
We recently published a list of the 7 Best Revenue Growth Stocks to Buy According to Analysts. In this article, we are going to take a look at where Genmab A/S (NASDAQ:GMAB) stands against the other best revenue growth stocks to buy according to analysts. The Fed recently cut the funds rate by 50 basis […]
Insider MonkeyGenmab A/S (GMAB): One of the Best Affordable Stocks Under $40 According to Short Sellers
We recently compiled a list of the 10 Best Affordable Stocks Under $40 According to Short Sellers. In this article, we are going to take a look at where Genmab A/S (NASDAQ:GMAB) stands against the other affordable stocks under $40. Several traders tend to profit from stocks through appreciation. However, some do the opposite– their idea […]
ZacksAbbVie (ABBV) Gets Nod in EU for Lymphoma Drug's Expanded Use
AbbVie's (ABBV) Tepkinly gets conditional approval in the EU to treat third-line patients with relapsed or refractory follicular lymphoma as a second indication.
